Initiating first-line (1L) Ibrutinib (Ibr) in patients (pts) with chronic lymphocytic leukemia (CLL) improves overall survival (OS) outcomes to rates approximating an age-matched population of ≥65 years Meeting Abstract
| Authors: | Ghia, P.; Owen, C.; Barrientos, J. C.; Barr, P. M.; Mato, A. R.; Shi, C. X.; Szoke, A.; Abbazio, C.; Krigsfeld, G. S.; Burger, J. A. |
| Abstract Title: | Initiating first-line (1L) Ibrutinib (Ibr) in patients (pts) with chronic lymphocytic leukemia (CLL) improves overall survival (OS) outcomes to rates approximating an age-matched population of ≥65 years |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 4159 |
| End Page: | 4161 |
| Language: | English |
| ACCESSION: | WOS:000893223204074 |
| DOI: | 10.1182/blood-2022-163257 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
